Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | SLC25A37 |
| Upstream (Parents) |
|---|
| (<<) ACTN1 → SLC25A37 |
| (<<) ADAM17 → SLC25A37 |
| (<<) CHST12 → SLC25A37 |
| (<<) EIF2C2 → SLC25A37 |
| (<<) EML4 → SLC25A37 |
| (<<) FZD4 → SLC25A37 |
| (<<) HIPK1 → SLC25A37 |
| (<<) MAP3K2 → SLC25A37 |
| (<<) NOL9 → SLC25A37 |
| (<<) PDPK1 → SLC25A37 |
| (<<) PIK3CA → SLC25A37 |
| (<<) PLOD2 → SLC25A37 |
| (<<) PRKCH → SLC25A37 |
| (<<) PRKCI → SLC25A37 |
| (<<) RCAN1 → SLC25A37 |
| (<<) RXRB → SLC25A37 |
| (<<) STAT3 → SLC25A37 |
| (<<) THOC4 → SLC25A37 |
| (<<) TK2 → SLC25A37 |
| Downstream (Children) |
|---|
| SLC25A37 → ARID3B (>>) |
| SLC25A37 → CASP9 (>>) |
| SLC25A37 → CDR2 (>>) |
| SLC25A37 → DDX18 (>>) |
| SLC25A37 → ERRFI1 (>>) |
| SLC25A37 → FA2H (>>) |
| SLC25A37 → GNB4 (>>) |
| SLC25A37 → GRB10 (>>) |
| SLC25A37 → INSR (>>) |
| SLC25A37 → ITPR2 (>>) |
| SLC25A37 → KCNJ2 (>>) |
| SLC25A37 → LRP5 (>>) |
| SLC25A37 → MAP6D1 (>>) |
| SLC25A37 → MEF2A (>>) |
| SLC25A37 → MOBKL2C (>>) |
| SLC25A37 → MT1F (>>) |
| SLC25A37 → MT1G (>>) |
| SLC25A37 → MT1P2 (>>) |
| SLC25A37 → PFDN2 (>>) |
| SLC25A37 → PI3 (>>) |
| SLC25A37 → PPP3CB (>>) |
| SLC25A37 → SLC6A14 (>>) |
| SLC25A37 → SLPI (>>) |
| SLC25A37 → SOD2 (>>) |
| SLC25A37 → SPATA2L (>>) |
| SLC25A37 → STX1A (>>) |
| SLC25A37 → TM4SF1 (>>) |
| SLC25A37 → TSPAN10 (>>) |
| SLC25A37 → WWTR1 (>>) |
